2 results
Approved WMOPending
The objective of this clinical study is to prove the safety of the CorNeat KPro.
Approved WMOCompleted
The primary objective is to compare the efficacy, as measured by recurrence-free survival (RFS) by blinded independent central review (BICR), of bempegaldesleukin plus nivolumab versus nivolumab in patients with completely resected Stage IIIA (lymph…